News Daily News Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor Michael O'Riordan April 12, 2019
News Daily News New Genetic Evidence Shows Alcoholic Drinks Don’t Cut Stroke Risk Yael L. Maxwell April 09, 2019
News Conference News ACC 2019 New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin Shelley Wood March 26, 2019
News Conference News ACC 2019 REDUCE-IT Subanalysis: Icosapent Ethyl Reduces Total and Recurrent CV Events Yael L. Maxwell March 22, 2019
News Daily News ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD Michael O'Riordan March 01, 2019
News Conference News ISC 2019 Final ANNEXA-4 Results Published, Confirm Rapid Andexanet Alfa Effects Todd Neale February 13, 2019
News Daily News Human Papilloma Virus May Contribute to CVD Risk in Women, Korean Study Finds L.A. McKeown February 08, 2019
News Daily News Age Shouldn’t Be a Barrier to Statin Therapy, Meta-analysis Suggests Michael O'Riordan February 08, 2019
News Daily News Most Cardiovascular Drugs Can Be Safely Used in Pregnancy, Review Suggests Todd Neale February 01, 2019
News Daily News Gasp! Cardiorespiratory Fitness Falling Over Time, Duke Study Suggests Michael O'Riordan January 23, 2019
News Daily News Dose-Response Benefits for Fiber Intake Seen Across Wide Swath of Acquired Diseases Shelley Wood January 15, 2019
News Daily News Stroke Risk Increases Over Time in Many Patients With A-fib Todd Neale January 08, 2019
News Conference News WCC 2018 Rising CVD Threatens Middle East and North Africa Todd Neale December 13, 2018
News Conference News WCC 2018 Man’s Best Friend, Especially After an MI or Stroke Todd Neale December 11, 2018
News Daily News Angina Without Obstructive Stenosis: No Longer a ‘Black Box’ Mystery, Say Experts Michael O'Riordan November 23, 2018
News Daily News Staged PCI or Complete Revasc? Physicians’ Practice Patterns Dictate Procedures Michael O'Riordan November 20, 2018
News Conference News AHA 2018 Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study Michael O'Riordan November 15, 2018
News Conference News AHA 2018 DECLARE-TIMI 58 Supports HF Benefit of SGLT2 Inhibitors Todd Neale November 10, 2018
News Daily News ODYSSEY Outcomes Published as New Cholesterol Guidelines Loom Michael O'Riordan November 07, 2018